TY - JOUR
T1 - Staged intrastromal delivery of riboflavin with UVA cross-linking in advanced bullous keratopathy
T2 - Laboratory investigation and first clinical case
AU - Krueger, Ronald R.
AU - Ramos-Esteban, Jerome C.
AU - Kanellopoulos, A. John
PY - 2008/9
Y1 - 2008/9
N2 - PURPOSE: To evaluate the safety and efficacy of staged ultraviolet A (UVA) cross-linking following intrastromal 0.1% riboflavin administration in eyes with advanced corneal edema. METHODS: Ten eye bank corneas divided in two groups (n=5) were placed on a pressurized artificial anterior chamber following Descemet's membrane stripping. Two consecutive corneal pockets (350- and 150-μm depth) were sequentially created using a femtosecond laser. Sequential intrastromal injections of 0.1% riboflavin (0.2 ml) followed by either UVA irradiation (15 mW/cm2) for 7 minutes or exposure to air were performed for each pocket. Corneal clarity and central thickness were measured before and after the two UVA cross-linking steps. The same steps were clinically applied in an 84-year-old woman with bullous keratopathy prior to corneal transplantation and followed for 6 months. RESULTS: The corneal clarity improved in the treated but not the control eyes. The mean central corneal thickness was significantly reduced by 256 μm (ultrasound, P=.0002) and 273 μm (Scheimpflug, P=.0004) in treated eyes, but only 100 μm (ultrasound, P=.048) and 107 μm (Scheimpflug, P=.075) in the control eyes. The clinical treatment of corneal edema showed improved clarity and reduced central corneal thickness from 675 to 550 μm (ultrasound) and 696 to 571 μm (Scheimpflug) at 1 month. Best spectacle-corrected visual acuity improved from finger counting to 20/80 at 1 week and beyond, postponing corneal transplantation for >6 months. CONCLUSIONS: Staged UVA cross-linking (15 mW/cm2) with femtosecond laser facilitated intrastromal 0.1% riboflavin administration may be a safe (no corneal scarring) and effective (marked reduction of edema) temporizing alternative method for managing bullous keratopathy.
AB - PURPOSE: To evaluate the safety and efficacy of staged ultraviolet A (UVA) cross-linking following intrastromal 0.1% riboflavin administration in eyes with advanced corneal edema. METHODS: Ten eye bank corneas divided in two groups (n=5) were placed on a pressurized artificial anterior chamber following Descemet's membrane stripping. Two consecutive corneal pockets (350- and 150-μm depth) were sequentially created using a femtosecond laser. Sequential intrastromal injections of 0.1% riboflavin (0.2 ml) followed by either UVA irradiation (15 mW/cm2) for 7 minutes or exposure to air were performed for each pocket. Corneal clarity and central thickness were measured before and after the two UVA cross-linking steps. The same steps were clinically applied in an 84-year-old woman with bullous keratopathy prior to corneal transplantation and followed for 6 months. RESULTS: The corneal clarity improved in the treated but not the control eyes. The mean central corneal thickness was significantly reduced by 256 μm (ultrasound, P=.0002) and 273 μm (Scheimpflug, P=.0004) in treated eyes, but only 100 μm (ultrasound, P=.048) and 107 μm (Scheimpflug, P=.075) in the control eyes. The clinical treatment of corneal edema showed improved clarity and reduced central corneal thickness from 675 to 550 μm (ultrasound) and 696 to 571 μm (Scheimpflug) at 1 month. Best spectacle-corrected visual acuity improved from finger counting to 20/80 at 1 week and beyond, postponing corneal transplantation for >6 months. CONCLUSIONS: Staged UVA cross-linking (15 mW/cm2) with femtosecond laser facilitated intrastromal 0.1% riboflavin administration may be a safe (no corneal scarring) and effective (marked reduction of edema) temporizing alternative method for managing bullous keratopathy.
UR - http://www.scopus.com/inward/record.url?scp=51149115767&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=51149115767&partnerID=8YFLogxK
U2 - 10.3928/1081597x-20080901-17
DO - 10.3928/1081597x-20080901-17
M3 - Article
C2 - 18811120
AN - SCOPUS:51149115767
SN - 1081-597X
VL - 24
SP - S730-S736
JO - Journal of Refractive Surgery
JF - Journal of Refractive Surgery
IS - 7
ER -